University of Washington study looks at GLP-1 medications and gambling
The University of Washington's ADAI has launched the GAME Study to learn how GLP-1 medications such as Ozempic and Wegovy affect people who gamble.
The Addictions, Drug & Alcohol Institute (ADAI) at the University of Washington has launched the GAME Study to better understand how taking a GLP-1 impacts betting behaviors. The researchers want to hear from people who gamble and take a GLP-1 medication such as Ozempic or Wegovy.
How the study works
Those interested must first answer a brief online questionnaire. Selected individuals would then meet with a member of the study team over Zoom to show their identification and GLP-1 prescription or medication label on camera. Participants would then be invited to complete a 30-minute survey about gambling urges, thoughts and behaviors before and after starting a GLP-1. Those who complete the three steps will be compensated with a $50 gift card. Lostutter said qualified participants will have experienced some sort of gambling-related harm, whether currently or in the past before going on a GLP-1. Participants will have their name and other identifiable information kept separate from the study data. The GAME Study is being funded by an ADAI Small Grant.
Researcher’s view
Ty Lostutter, an associate professor at UW Psychiatry & Behavioral Sciences, says problem gambling is a rapidly growing public health crisis fueled by legalized sports betting. He said there has been growing interest in the potential effects of these medications on addictive behaviors, but that researchers still have much to learn about their relationship to gambling.
Other research
Researchers at the University of Pennsylvania believe GLP-1 medications can help problem gamblers. Boston University has also published early research regarding a link to easing gambling urges through a GLP-1.
Sources
- Casino.org News · Industry media · primary source ·
Spotted a mistake? Report an error — see our corrections policy.